Log in
Donate
Search
Close this search box.

Clinical Trial: ALLIANCE A011106

ALLIANCE A011106

Status: Closed

NCT#01953588

ALTernate Approaches for Clinical Stage II and III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment [ALTERNATE] in Postmenopausal Women: A Phase III Study

A011106 is closed to accrual, effective July 15th, 2019.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved